Spencer Curtis in

Spencer Curtis

Questioner · DISC type c
Senior Director, Commercial Learning & Development at Cytokinetics
📍 Philadelphia, Pennsylvania, United States

Spencer Curtis is the Senior Director of Commercial Learning & Development at Cytokinetics, with extensive experience from senior roles at Otsuka Pharmaceutical and Bristol-Myers Squibb. He specializes in merging tactical planning with biotechnology ventures and has a background in business excellence from Columbia Business School.

Outside of his corporate roles, Spencer is passionate about professional growth and making meaningful connections. He actively engages in mentoring programs and shows a keen interest in the principles of authentic leadership, as highlighted by his public appreciation for content on the topic.

He has signed up for the Cyto Exchange 2025 program with the goal of mentoring, sharing, and learning with other professionals.

Read the full overview →
Current Role
Senior Director, Commercial Learning & Development
Location
Philadelphia, Pennsylvania, United States
Personality Overview

How Spencer shows up

Not Easily Convinced
Price-Sensitive
Value Seeker

They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. It is quite likely of them to ask for pricing or other concessions.

Priorities

Topics Spencer cares about

Commercial Leadership
Holds senior commercial and business director roles at Cytokinetics and Otsuka, focusing on learning, development, and strategic planning in the pharmaceutical industry.
Biotechnology Ventures
His work involves merging tactical planning with the ambitious objectives of biotechnology ventures to establish a robust market presence and deliver impactful healthcare solutions.
+5 more topics Login to view topics
Career

Work history

12-2024
Senior Director, Commercial Learning & Development
Cytokinetics
5-2023 - 12-2024
Senior Business Director- Tristate Region
Otsuka Pharmaceutical Companies (U.S.)
5-2021 - 5-2023
Head of Digital Portfolio Strategy
Otsuka Pharmaceutical Companies (U.S.)
10-2020 - 5-2021
Senior Director, CNS Portfolio Strategy and Asset Management
Otsuka Pharmaceutical Companies (U.S.)
1-2020 - 10-2020
Director, US Oncology Franchise Marketing Strategy & Operations
Bristol-Myers Squibb
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
Business Excellence
Columbia Business School
Bachelor of Business Administration - BBA
Columbus State University
Social presence
in
Behavioral profile

DISC profile (public)

c

Calculativeness (C)

Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.

Other Cytokinetics Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Spencer. Free, 10 seconds.